LINC Asia-Pacific is an interdisciplinary live course, designed to provide a global platform, permitting the discussion of the „vascular patients“ by integrating colleagues of different specialties who are performing endovascular interventions.
Room 1 - Main Arena
17 events
Tuesday, March 13th:
-
,
Room 1 - Main Arena
"Leave nothing behind!" – The new paradigm for SFA treatment? Update on latest DCB data, limitations, and future concepts
Live case transmission from the Chinese University of Hong Kong, Prince of Wales Hospital
The Chinese University of Hong Kong, Prince of Wales Hospital- Live case center
DCB CLINICAL TRAIL UPDATE
-
EFFPAC-RCT: final 6-month results with the Luminor DCB
UlfTeichgräber
-
LUTONIX® 035 DCB – long lesion 24-month outcomes
Skyi Yin ChunPang, Via satellite from Prince Wales Hospital, Hong Kong
-
The RANGER clinical trial programme: 12-month results from the RANGER RCT and first look at the COMPARE I study of RANGER vs. IN.PACT for femoropopliteal lesions
DierkScheinert
-
DCB in Japan – evidences and clinical adaptation
YoshimitsuSoga
DCB IN REAL WORLD: HOW FAR HAVE WE COME WITH THE "LEAVE NOTHING BEHIND" CONCEPT?
-
DCB changes the manner
Sea-WonLee
-
Promise and limitations of DCB in long lesions: what have we learned from clinical trials?
RamonVarcoe
-
Live case transmission from Seoul National University Hospital, Republic of Korea
Seoul National University Hospital- Live case center
-
The importance of vessel preparation and how to do it
RalfLanghoff
-
Comparison of angiographic dissection patterns between long and short length balloons following balloon angioplasty for chronic femoropopliteal occlusions
MichinaoTan
-
Directional atherectomy and anti-restenotic therapy – Hong Kong experience and update
BryanYan, Via satellite from Prince Wales Hospital, Hong Kong
-
Live case transmission from Beijing PLA Hospital, Beijing, China
Beijing PLA Hospital- Live case center
-
Discussion and conclusion
Tuesday, March 13th:
-
,
Room 1 - Main Arena
Symposium: the latest data and approach to managing complex lesions and patients
supported with an educational grant from
Medtronic
Moderator:
CarlosMena-Hurtado
Panel:
YoshimitsuSoga,
Jen KuangLee
-
IN.PACT China: 12-month results of IN.PACT DCB in a Chinese population
WeiGuo, Via satellite from Beijing PLA Hospital, Beijing
-
IN.PACT Japan trial 2-year results
YoshimitsuSoga
-
Update on the IN.PACT clinical program: IN.PACT SFA 4-year results and IN.PACT Global 2-year results
StevenKum, Via satellite from Prince Wales Hospital, Hong Kong
-
Live case transmission from the Chinese University of Hong Kong, Prince of Wales Hospital
The Chinese University of Hong Kong, Prince of Wales Hospital- Live case center
-
1-year result of the real-world experience of DAART in Taiwan
Jen KuangLee
-
My approach to managing complex, multilevel disease
Safety and efficacy of distal superficial femoral artery puncture for femoropopliteal occlusive lesions – results from the multicenter REVERside registry
TatsuyaNakama
-
DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes
CarlosMena-Hurtado
-
Comparison between long stenting and proximal spot stenting for long chronic total occlusion of the femoropopliteal artery
TsuyoshiNakata
-
Live case transmission from Beijing PLA Hospital, Beijing, China
Beijing PLA Hospital- Live case center
-
Clinical outcome comparison between covered stent and drug eluting balloon
MingLi
-
Discussion
Wednesday, March 14th:
-
,
Room 1 - Main Arena
Advanced femoropopliteal interventions – Focus on new stent technologies and DES
Moderator:
RalfLanghoff,
WeiLiang
Panel:
UlfTeichgräber,
DaizoKawasaki
-
Experience, tips and tricks with the Jetstream atherectomy system
Sea-WonLee
-
Live case transmission from Seoul National University Hospital, Republic of Korea
Seoul National University Hospital- Live case center
-
Inflow management of CLI with the Supera stent
StevenKum, Via satellite from Prince Wales Hospital, Hong Kong
-
Supera stent - Long term results in Asia
Yiu-CheChan
-
MAJESTIC 3-year data
Tze TecChong
-
Live case transmission from the Chinese University of Hong Kong, Prince of Wales Hospital
The Chinese University of Hong Kong, Prince of Wales Hospital- Live case center
-
12-month outcomes in the EVOLUTION study: investigating the iVolution stent in femoropopliteal lesions
IsuruNamunni
-
Is there a role for an interwoven nitinol stent beyond the SFA?
Yiu-CheChan
-
Discussion
Wednesday, March 14th:
-
,
Room 1 - Main Arena
Lunch
Wednesday, March 14th:
-
,
Room 1 - Main Arena
Bard innovations for arterial & venous endovascular interventions
supported with an educational grant from
C. R. Bard
Moderator:
DierkScheinert
Panel:
Jimmy Wei-HwaTan,
DaizoKawasaki,
Je-HwanWon,
Tze TecChong,
I-MingChen,
RahulN.S
-
Update from Korea on the Lutonix SFA registry 12-month data
Je-HwanWon
-
First interim look at the Singapore Lutonix DCB AV registry
Tze TecChong
-
Live case transmission from University Hospital Leipzig, Germany
University Hospital Leipzig, Dep. Angiology- Live case center
-
First look at Taiwan BTK data for Lutonix DCB
I-MingChen
-
First look at Indian BTK data for Lutonix DCB
RahulN.S
-
Real world Japanese experience with Crosser
DaizoKawasaki
-
The role of COVERA™ vascular covered stent
Jimmy Wei-HwaTan
-
Multidisciplinary cooperation on VTE prevention and management
TaoYang
-
Discussion and conclusion
Wednesday, March 14th:
-
,
Room 1 - Main Arena
The last frontiers: management of thrombus containing lesions, calcification, and in-stent restenosis
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and legal notice.